LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Conference Material > Slide Presentation

24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial

Berry C, Motta I, Kazounis E, Fielding K, Dodd M, Nyang'wa BT, Moodliar R
Download
Download
No Abstract Available
Countries
BelarusSouth AfricaUzbekistan
Subject Area
antibiotic resistancetuberculosisantimicrobial resistance
DOI
10.57740/v9ye-0032
Published Date
11-May-2022
Languages
English
Conference
MSF Scientific Days International 2022

Linked Items

Conference Material > Abstract
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
11-May-2022
Conference Material > Video
24-week regimens for treatment of rifampicin-resistant tuberculosis: four-arm randomised trial
07-Jun-2022